CD44 and ependymoma: Clodronate-loaded and zoledronate acid-loaded liposomes have been applied to deplete TAMs resulted in decreasing tumor angiogenesis and progression in preclinical solid tumor models successfully, which indicate that these treatments could also be used to deplete CD44+ TAMs in spinal ependymoma.